Nordson Corporation — FY2022 Form 10-K
Reporting period: Fiscal year ended October 31, 2022. The filing is an annual report, not a standalone fourth-quarter report. Amounts below are in millions of U.S. dollars unless stated otherwise.
Business context
Nordson designs and manufactures precision dispensing, fluid-management, medical, surface-treatment, and test-and-inspection equipment for industrial, medical, electronics, packaging, and other markets. About 66.8% of FY2022 sales were generated outside the United States. In the fourth quarter, the company reorganized reporting into Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions.
Key financial results
| Metric | FY2022 | FY2021 |
|---|---|---|
| Sales | $2,590.3 | $2,362.2 |
| Gross margin | 55.1% | 56.1% |
| Operating profit | $702.4 | $615.1 |
| Operating margin | 27.1% | 26.0% |
| Net income | $513.1 | $454.4 |
| Diluted EPS | $8.81 | $7.74 |
| Cash from operating activities | $513.1 | $545.9 |
| Capital expenditures | $51.4 | $38.3 |
Sales rose 9.7%: organic growth, including pricing, was 10.8%; acquisitions and divestitures added a net 3.3%; and currency translation reduced sales 4.4%. Net income included a $41.2 million noncash pension settlement charge. The reported effective tax rate was 21.0%.
Segments and material changes
- Industrial Precision Solutions: Sales of $1,337.2 million, up 7.2%; operating margin was 32.5%, down from 33.2%. Nonwovens sales declined while other product lines generally grew.
- Medical and Fluid Solutions: Sales of $690.2 million, up 7.6%; operating margin increased to 31.5% from 30.9%.
- Advanced Technology Solutions: Sales of $562.9 million, up 18.8%; operating margin increased to 23.7% from 15.5%.
Gross margin declined by 1.0 percentage point, which management attributed primarily to inflationary cost pass-through. Lower selling and administrative expense as a share of sales—28.0% versus 30.0%—supported operating-margin expansion. Net income and diluted EPS increased 12.9% and 13.8%, respectively.
Cash, debt, and liquidity
- Operating cash flow was $513.1 million, down from $545.9 million; working-capital changes used $107.3 million, with higher receivables and inventory associated with business growth.
- Cash and cash equivalents were $163.5 million, down $136.5 million year over year. Cash used in investing activities was $222.8 million; cash used in financing activities was $416.0 million.
- Total debt was $738.8 million, down $78.0 million; 35% of debt had floating rates. Current maturities were $392.5 million, principally reflecting debt due in 2023. The company reported compliance with debt covenants.
- Nordson had an $850 million revolving credit facility expiring in April 2024, with no balance outstanding at October 31, 2022. Management said available cash, operating cash flow, and borrowing capacity should cover foreseeable liquidity needs.
- Cash used for share repurchases was $262.9 million; dividends paid were $125.9 million. The annual dividend declared per share rose to $2.18 from $1.69.
Outlook, risks, and unusual items
The filing provides no specific numerical sales, earnings, or cash-flow guidance. Management describes its long-term Ascend strategy as focused on profitable growth, margins, returns, customer solutions, and acquisitions, while cautioning that quarterly results may fluctuate.
- Acquisitions: Nordson acquired NDC Technologies on November 1, 2021 for $171.6 million net of cash and adjustments. On November 3, 2022, after year-end, it completed the CyberOptics acquisition for approximately $380 million net of cash acquired, funded with its revolving credit facility. CyberOptics expands semiconductor and electronics inspection capabilities.
- Pension settlement: A partial U.S. pension settlement transferred obligations for about 1,500 retirees and beneficiaries to an insurer. The transaction generated a $41.2 million charge; plan assets of $171.2 million funded the annuity purchase.
- Operating and market risks: Management identifies inflation, supply constraints—especially electronic components—higher logistics costs, foreign-exchange movements, economic and end-market cyclicality, China COVID-19 restrictions, and geopolitical and trade-policy uncertainty as risks.
- Other exposures: Risks include acquisition integration and goodwill impairment, cybersecurity and data privacy, environmental and regulatory compliance, pension assumptions, and interest-rate changes. A 1 percentage-point increase in rates on floating-rate debt would have increased FY2022 interest expense by about $2.8 million.
- Contingencies and controls: The company reported no material legal proceedings. Its New Richmond, Wisconsin environmental remediation accrual was $0.3 million; management did not expect a material adverse effect. Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting.
Important facts for investors to verify
- How quickly the $392.5 million of current debt maturities will be repaid, refinanced, or otherwise funded, and the effect of borrowing for CyberOptics.
- Whether sales growth and segment margins can be sustained as inflation, currency headwinds, and supply constraints evolve.
- CyberOptics’ integration, financing cost, and realized contribution to Advanced Technology Solutions; the filing does not provide post-acquisition operating results.
- The cash-flow and working-capital trend, particularly receivables and inventory, alongside continued dividends and share repurchases.
- The sensitivity of goodwill valuations and pension obligations to economic, discount-rate, and operating assumptions.